×

What's behind these pharma M&A deals?

5:00 AM ET Tue, 22 April 2014

The M&A activity in the pharmaceutical sector reveals that the industry is planning for the next 15-20 years, and is an opportunity for groups to diversify their tax bases, CNBC's Catherine Boyle explains.